Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on: January 26,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on:January 26,2024

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Updated on: March 30,2024

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Updated on:March 30,2024

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer

Updated on: January 04,2024

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer

Updated on:January 04,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024

Study finds nearly half of top cancer centers required universal masking during last winter's COVID-19 surge

byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du

Updated on: August 27,2024

Study finds nearly half of top cancer centers required universal masking during last winter's COVID-19 surge

byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du

Updated on:August 27,2024

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on: December 28,2023

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on:December 28,2023

Researchers devise novel solution to preventing relapse after CAR T-cell therapy

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainEven as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant

Updated on: August 28,2024

Researchers devise novel solution to preventing relapse after CAR T-cell therapy

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainEven as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant

Updated on:August 28,2024

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

Updated on: May 06,2024

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

Updated on:May 06,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on: June 22,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on:June 22,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on: March 15,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on:March 15,2024